To include your compound in the COVID-19 Resource Center, submit it here.

Istradefylline: Phase III data

A double-blind, Japanese Phase III trial in 373 PD patients with motor complications who were receiving levodopa showed that once-daily 20 and 40 mg KW-6002

Read the full 254 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE